As of 2025-01-22, the EV/EBITDA ratio of Insmed Inc (INSM) is -19.79. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INSM's latest enterprise value is 13,493.13 mil USD. INSM's TTM EBITDA according to its financial statements is -681.65 mil USD. Dividing these 2 quantities gives us the above INSM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.0x - 16.1x | 16.0x |
| Forward P/E multiples | 14.9x - 17.4x | 15.6x |
| Fair Price | (60.14) - (64.18) | (62.92) |
| Upside | -182.9% - -188.5% | -186.8% |
| Date | EV/EBITDA |
| 2025-01-17 | -19.79 |
| 2025-01-16 | -19.86 |
| 2025-01-15 | -19.19 |
| 2025-01-14 | -18.69 |
| 2025-01-13 | -18.86 |
| 2025-01-10 | -17.89 |
| 2025-01-08 | -18.01 |
| 2025-01-07 | -18.12 |
| 2025-01-06 | -18.25 |
| 2025-01-03 | -19.10 |
| 2025-01-02 | -19.12 |
| 2024-12-31 | -18.88 |
| 2024-12-30 | -18.84 |
| 2024-12-27 | -19.03 |
| 2024-12-26 | -19.31 |
| 2024-12-24 | -19.28 |
| 2024-12-23 | -19.29 |
| 2024-12-20 | -19.25 |
| 2024-12-19 | -18.98 |
| 2024-12-18 | -19.14 |
| 2024-12-17 | -20.15 |
| 2024-12-16 | -20.03 |
| 2024-12-13 | -19.56 |
| 2024-12-12 | -19.67 |
| 2024-12-11 | -20.24 |
| 2024-12-10 | -19.82 |
| 2024-12-09 | -19.86 |
| 2024-12-06 | -20.55 |
| 2024-12-05 | -20.53 |
| 2024-12-04 | -20.54 |
| 2024-12-03 | -19.77 |
| 2024-12-02 | -19.77 |
| 2024-11-29 | -20.49 |
| 2024-11-27 | -20.68 |
| 2024-11-26 | -20.63 |
| 2024-11-25 | -20.21 |
| 2024-11-22 | -19.96 |
| 2024-11-21 | -20.14 |
| 2024-11-20 | -19.84 |
| 2024-11-19 | -20.11 |
| 2024-11-18 | -18.25 |
| 2024-11-15 | -18.16 |
| 2024-11-14 | -19.47 |
| 2024-11-13 | -19.29 |
| 2024-11-12 | -19.17 |
| 2024-11-11 | -19.61 |
| 2024-11-08 | -20.07 |
| 2024-11-07 | -19.58 |
| 2024-11-06 | -19.89 |
| 2024-11-05 | -18.95 |